TIS 0.00% 0.0¢ tissue therapies limited

double blinded studies, page-7

  1. 492 Posts.
    The tight paramaters used a DB study will also increase the authority and accuracy (when incorporated) of health economics modeling - possibly strengthening VitroGrows competitive advantage as governments seek to reduce expenditures.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.